TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Idexx Laboratories Sverige AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
160,626
|
156,139
|
147,551 |
| Financial expenses |
14
|
9
|
5 |
| Earnings before taxes |
4,155
|
2,453
|
2,127 |
| EBITDA |
4,325
|
2,847
|
3,115 |
| Total assets |
52,985
|
43,552
|
31,164 |
| Current assets |
45,776
|
38,944
|
26,277 |
| Current liabilities |
28,792
|
21,832
|
11,335 |
| Equity capital |
24,193
|
21,720
|
19,829 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
20
|
20
|
17 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
45.7%
|
49.9%
|
63.6% |
| Turnover per employee |
8,031
|
7,807
|
8,679 |
| Profit as a percentage of turnover |
2.6%
|
1.6%
|
1.4% |
| Return on assets (ROA) |
7.9%
|
5.7%
|
6.8% |
| Current ratio |
159.0%
|
178.4%
|
231.8% |
| Return on equity (ROE) |
17.2%
|
11.3%
|
10.7% |
| Change turnover |
4,487
|
8,588
|
19,598 |
| Change turnover % |
3%
|
6%
|
15% |
| Chg. No. of employees |
0
|
3
|
0 |
| Chg. No. of employees % |
0%
|
18%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.